Single agent activity of U31402, a HER3-targeting antibody -drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results of a phase 1/2 trialN. Masuda,K. Yonemori,S. Takahashi,T. Kogawa,T. Nakayama, H. Iwase,M. Takahashi,T. Toyama,T. Saeki,S. Saji,K. Inoue,H. Onuma,N. Tajima, Y. Shiose,S. Chen, F. Guevara, C. Yu,S. Ueno,H. IwataCANCER RESEARCH（2019）引用 9|浏览28暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
